Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - Jazz Pharmaceuticals plc | jazzq42017ex321.htm |
| EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plc | jazzq42017ex312.htm |
| EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plc | jazzq42017ex311.htm |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Jazz Pharmaceuticals plc | jazzq42017ex231.htm |
| EX-10.26C - CASH BONUS PLAN 2018 - Jazz Pharmaceuticals plc | jazzq42017ex1026c.htm |
| EX-10.21 - OFFER LETTER - Jazz Pharmaceuticals plc | jazzq42017ex1021.htm |
| EX-10.8 - MANUFACTURING AND SUPPLY AGREEMENT - Jazz Pharmaceuticals plc | jazzq42017ex108.htm |
| 10-K - 10-K - Jazz Pharmaceuticals plc | jazz1231201710k.htm |
Exhibit 21.1
Subsidiaries of the Registrant
Name of Subsidiary | State or Jurisdiction of Incorporation or Organization |
Jazz Pharmaceuticals Ireland Limited | Ireland |
Jazz Financing I Designated Activity Company | Ireland |
Jazz Capital Limited | Ireland |
Jazz Pharmaceuticals, Inc. | Delaware |
Celator Pharmaceuticals, Inc. | Delaware |
Jazz Pharmaceuticals Europe Holdings Limited | Gibraltar |
Jazz Pharmaceuticals France SAS | France |
Jazz Pharmaceuticals Lux S.à r.l. | Luxembourg |
Gentium S.R.L. | Italy |